The effect of antifibrinolytic agents in periacetabular osteotomy: A systematic review and meta-analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Chul-Ho | - |
dc.contributor.author | Lim, Eic Ju | - |
dc.contributor.author | Kim, Siyeon | - |
dc.contributor.author | Kim, Ji Wan | - |
dc.date.accessioned | 2022-08-31T16:40:07Z | - |
dc.date.available | 2022-08-31T16:40:07Z | - |
dc.date.created | 2022-08-19 | - |
dc.date.issued | 2022-06 | - |
dc.identifier.issn | 1877-0568 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85352 | - |
dc.description.abstract | Background: Periacetabular osteotomy (PAO) is a major hip preservation surgery for developmental dysplasia of the hip. It is inevitably associated with significant blood loss, so it requires frequent transfusions and could be a cause of perioperative morbidity. However, to date, a large number of studies has not evaluated the effect of antifibrinolytic agents in PAO. Therefore we performed a systematic review and meta-analysis to assess if antifibrinolytics would be effective in reducing blood loss and transfusion rate after PAO surgery. Methods: In this systematic review and meta-analysis, MEDLINE, Embase, and Cochrane Library databases were systematically searched for studies published before April 4, 2020, that investigated the effect of antifibrinolytic agents in PAO. A pooled analysis was designed to identify differences between antifibrinolytic and control groups focusing on blood loss, transfusion, operation time, postoperative venous thromboembolism (VTE), and length of hospital stay. Results: We included five studies involving 507 patients (antifibrinolytic group: 256; control group: 251). The pooled analysis showed that the control group had a greater total estimated blood loss (EBL) than the antifibrinolytic group (mean difference [MD] = -257.60 mL, 95% confidence interval [CI] -389.68 to -125.53, p = 0.0001), but there were no statistical differences in intraoperative EBL (MD = -46.46 mL, 95% CI: -192.57 to 99.64, p = 0.53). The allogenic transfusion rate was higher in the control group than in the antifibrinolytic group (odds ratio [OR] 0.21, 95% CI: 0.10-0.43, p < 0.0001), but there was no difference in the autogenic transfusion rate (OR 0.35, 95% CI: 0.09-1.43, p = 0.14). The pooled result showed no difference in operation time (MD = 9.13 min, 95% CI: -8.54 to 26.80, p = 0.31). For the VTE rate, a pooled analysis was not conducted due to the lack of data. The length of hospital stay showed no differences (MD = -0.51 days, 95% CI: -1.17 to 0.16, p = 0.13). Conclusions: Antifibrinolytic use in PAO has positive effects in terms of reduced total EBL and allogenic transfusion rate. Level of evidence: III; meta-analysis. (C) 2022 Elsevier Masson SAS. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER MASSON, CORP OFF | - |
dc.relation.isPartOf | ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH | - |
dc.title | The effect of antifibrinolytic agents in periacetabular osteotomy: A systematic review and meta-analysis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000814435500010 | - |
dc.identifier.doi | 10.1016/j.otsr.2022.103271 | - |
dc.identifier.bibliographicCitation | ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, v.108, no.4 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85130435734 | - |
dc.citation.title | ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH | - |
dc.citation.volume | 108 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Kim, Siyeon | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Antifibrinolytics | - |
dc.subject.keywordAuthor | Antifibrinolytic agent | - |
dc.subject.keywordAuthor | Tranexamic acid | - |
dc.subject.keywordAuthor | Epsilon-aminocaproic acid | - |
dc.subject.keywordAuthor | Periacetabular osteotomy | - |
dc.subject.keywordAuthor | Meta-analysis | - |
dc.subject.keywordPlus | REDUCES BLOOD-LOSS | - |
dc.subject.keywordPlus | TRANEXAMIC ACID | - |
dc.subject.keywordPlus | TRANSFUSION REQUIREMENTS | - |
dc.subject.keywordPlus | TOTAL HIP | - |
dc.subject.keywordPlus | KNEE REPLACEMENT | - |
dc.subject.keywordPlus | DYSPLASIA | - |
dc.relation.journalResearchArea | Orthopedics | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Orthopedics | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.